NGL Fine Chem Stock Screener | Share Price & Fundamental Analysis
NGLFINE
Pharmaceuticals
Screen NGL Fine Chem share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1430.50
▲
5.80 (0.41%)
Share Price BSE
₹1426.45
▼
-0.55 (-0.04%)
Market Cap
₹822.85 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.68
EPS (TTM)
₹34.19
Dividend Yield
0.13%
Debt to Equity
0.20
52W High
₹2011.25
52W Low
₹983.15
Operating Margin
7.00%
Profit Margin
1.06%
Revenue (TTM)
₹94.00
EBITDA
₹5.00
Net Income
₹1.00
Total Assets
₹433.00
Total Equity
₹282.00
NGL Fine Chem Share Price History - Stock Screener Chart
Screen NGLFINE historical share price movements with interactive charts. Analyze price trends and patterns.
NGL Fine Chem Company Profile - Fundamental Screener
Screen NGL Fine Chem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NGLFINE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE887E01022
NGL Fine Chem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NGLFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 433 | 356 | 287 | 277 | 207 | 154 | 142 |
| Current Assets | 235 | 213 | 163 | 174 | 125 | 81 | 79 |
| Fixed Assets | 143 | 86 | 88 | 89 | 64 | 68 | 61 |
| Liabilities | |||||||
| Total Liabilities | 433 | 356 | 287 | 277 | 207 | 154 | 142 |
| Current Liabilities | 32 | 6 | 6 | 8 | 11 | 12 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 282 | 263 | 223 | 203 | 155 | 99 | 92 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 279 | 260 | 220 | 200 | 151 | 96 | 89 |
Screen NGLFINE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94 | 111 | 122 | 103 | 97 | 99 | 89 | 76 | 74 | 83 | 92 | 87 | 68 | 68 | 73 |
| Expenses | 89 | 93 | 103 | 84 | 81 | 82 | 84 | 61 | 61 | 66 | 74 | 74 | 63 | 59 | 62 |
| EBITDA | 5 | 17 | 19 | 20 | 15 | 17 | 5 | 15 | 13 | 17 | 18 | 14 | 5 | 10 | 11 |
| Operating Profit % | 7.00% | 11.00% | 14.00% | 16.00% | 10.00% | 12.00% | 6.00% | 19.00% | 14.00% | 17.00% | 16.00% | 13.00% | 3.00% | 14.00% | 14.00% |
| Depreciation | 3 | 4 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 1 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 |
| Profit Before Tax | 1 | 12 | 13 | 16 | 12 | 13 | 1 | 12 | 10 | 14 | 14 | 9 | 1 | 6 | 9 |
| Tax | 1 | 3 | 3 | 4 | 3 | 4 | 0 | 3 | 2 | 4 | 4 | 2 | 0 | 2 | 3 |
| Net Profit | 1 | 9 | 10 | 12 | 9 | 10 | 1 | 9 | 9 | 11 | 10 | 7 | 1 | 5 | 7 |
| EPS | 0.88 | 14.96 | 15.58 | 19.95 | 14.92 | 15.88 | 2.07 | 15.09 | 13.77 | 16.96 | 16.24 | 11.12 | 0.84 | 7.56 | 10.50 |
NGL Fine Chem Cash Flow Screener - Liquidity Fundamentals
Screen NGLFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 36 | 21 | 35 | 14 | 27 | 21 | 9 |
| Investing Activities | -35 | -27 | -27 | -14 | -25 | -20 | -10 |
| Financing Activities | -1 | -1 | -1 | -1 | -1 | -1 | 0 |
| Net Cash Flow | 0 | -7 | 7 | -2 | 2 | 0 | -1 |
Screen NGLFINE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 73.53% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.10% | 0.03% | 0.02% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.75% | 23.00% | 23.01% | 21.85% | 21.81% | 21.69% | 21.70% | 21.95% |
| Other Holding | 4.51% | 4.27% | 4.25% | 5.31% | 5.42% | 5.56% | 5.56% | 4.52% |
| Shareholder Count | 14,386 | 14,010 | 13,387 | 15,041 | 14,608 | 14,575 | 14,110 | 18,287 |
NGL Fine Chem Dividend Screener - Share Yield Analysis
Screen NGLFINE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.75 | 0.14% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.75 | 0.08% |
| 2022-March | ₹1.75 | 0.14% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
NGL Fine Chem Index Membership - Market Screener Classification
Screen NGLFINE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
NGL Fine Chem Market Events Screener - Corporate Actions
Screen NGLFINE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.76% |
| 2025-08-19 | 2025-08-19 | Annual General Meeting | NA | 6.32% |
| 2025-08-12 | 2025-08-12 | Dividend | ₹ 1.75 /share | -5.16% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -0.55% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 15.10% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 16.09% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 9.98% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -1.27% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 1.75 /share | -0.27% |
| 2023-08-18 | 2023-08-18 | Dividend | ₹ 1.75 /share | 31.25% |
| 2022-06-22 | 2022-06-23 | Dividend | ₹ 1.75 /share | -23.99% |
| 2021-08-12 | 2021-08-13 | Dividend | ₹ 1.75 /share | 79.24% |
NGL Fine Chem Competitors Screener - Peer Comparison
Screen NGLFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
NGL Fine Chem Company Announcements - News Screener
Screen NGLFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Results For Quarter Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-03 | Board Meeting Intimation for Notice Of The Third Board Meeting Of 2025-26 | View |
| 2025-10-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-08-19 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-19 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-07 | Regulation 30 Updates | View |
| 2025-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-08-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-01 | Financial Results For Quarter Ended 30Th June 2025 | View |
| 2025-08-01 | Board Meeting Outcome for Outcome Of Board Meeting | View |